Esophageal cancer is a significant concern for patients diagnosed with head and neck squamous cell carcinoma (HNSCC), as these individuals are at an increased risk of developing second primary ...
Hosted on MSN21d
Study reveals novel insights into the molecular pathology of esophageal squamous cell carcinomaEsophageal squamous cell carcinoma (ESCC) is a highly aggressive malignancy with poor prognosis, and understanding the molecular mechanisms underlying its progression is crucial for developing ...
The most common types of esophageal cancer are squamous cell carcinoma and adenocarcinoma. The American Cancer Society’s estimates about 16,940 new esophageal cancer cases diagnosed (13,360 in men and ...
Early and late responders with esophageal squamous cell carcinoma experienced comparable OS benefits with Tevimbra plus chemo ...
Reclassification of tumors at the gastroesophageal junction (GEJ) and/ or the proximal 5 cm of the stomach that extend into the GEJ or esophagus Reassignment of stage groupings using T ...
The safety and short-term efficacy of neoadjuvant chemotherapy in elderly patients with resectable locally advanced esophageal squamous cell carcinoma. This is an ASCO Meeting Abstract from the 2025 ...
Esophageal squamous cell carcinoma (ESCC) is a severe health threat, being a predominant subtype of esophageal cancer and contributing significantly to cancer-related mortality globally.
In resectable, locally advanced esophageal squamous cell carcinoma, neoadjuvant Tyvyt plus chemoradiotherapy led to an ...
Impact of time to surgery on outcomes in patients with advanced esophageal squamous cell carcinoma following neoadjuvant therapy: An exploratory analysis of phase III trial JCOG1109. This is an ASCO ...
Esophageal squamous cell carcinoma (ESCC) is a highly aggressive malignancy with poor prognosis, and understanding the molecular mechanisms underlying its progression is crucial for developing ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback